Janux Therapeutics (JANX) Asset Utilization Ratio: 2021-2025
Historic Asset Utilization Ratio for Janux Therapeutics (JANX) over the last 3 years, with Sep 2025 value amounting to 0.02.
- Janux Therapeutics' Asset Utilization Ratio rose 6.34% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year increase of 6.34%. This contributed to the annual value of 0.01 for FY2024, which is 32.37% down from last year.
- Per Janux Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.02 for Q3 2025, which was up 6.34% from 0.02 recorded in Q3 2024.
- In the past 5 years, Janux Therapeutics' Asset Utilization Ratio registered a high of 0.03 during Q1 2023, and its lowest value of 0.00 during Q3 2021.
- In the last 3 years, Janux Therapeutics' Asset Utilization Ratio had a median value of 0.02 in 2024 and averaged 0.02.
- Per our database at Business Quant, Janux Therapeutics' Asset Utilization Ratio skyrocketed by 297.24% in 2022 and then plummeted by 46.14% in 2024.
- Quarterly analysis of 5 years shows Janux Therapeutics' Asset Utilization Ratio stood at 0.01 in 2021, then surged by 146.76% to 0.02 in 2022, then decreased by 9.51% to 0.02 in 2023, then fell by 19.04% to 0.02 in 2024, then increased by 6.34% to 0.02 in 2025.
- Its Asset Utilization Ratio stands at 0.02 for Q3 2025, versus 0.02 for Q3 2024 and 0.02 for Q2 2024.